Načítá se...
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials
Monotherapy clinical trials with mutation-targeted kinase inhibitors, despite some success in other cancers, have yet to impact glioblastoma (GBM). Besides insufficient blood-brain-barrier penetration, combinations are key to overcoming obstacles such as intratumoral heterogeneity, adaptive resistan...
Uloženo v:
| Vydáno v: | ACS Chem Neurosci |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771884/ https://ncbi.nlm.nih.gov/pubmed/28950062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.7b00197 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|